Abstract
The structural and functional integrity of skeletal muscle depends on the presence and normal function of neuromuscular transmission. Problems may arise from pharmacologic manipulation of neuromuscular transmission and may lead to changes in the development, maintenance, and integrity of the end-plate and muscle fiber. The physiology of neuromuscular transmission can be affected in several ways. The amount of the transmitter acetylcholine (ACh) which is released may be increased or reduced by a wide variety of drugs (2, 6, 7, 11, 28, 29). Post-synaptic sensitivity may be changed by altering either the number of or the affinity of the ACh receptors. Drug induced changes of the input resistance of the muscle fiber membrane can alter the threshold for the generation of muscle action potentials. Variation in one of these factors or in combination with one another can be contributing causes of neuromuscular degeneration (4, 10, 16, 36, 39).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ariens, A.T., Meeter, E., Wolthuis, O.L. and van Benthem, R.M.J. (1969): Experientia 25:57–59.
Birks, R. and Maclntosh, F.C. (1961): Can. J. Biochem. Physiol. 39:787–827.
Bowman, W.C. and Webb, S.N. (1972): In International Encyclopedia of Pharmacology and Therapeutics (ed) J. Cheymol, Pergamon Press, Oxford, Sec. 14, Vol. 2, pp. 427–502.
Chang, C.C., Chen, T.F. and Chuang, S.T. (1973): J. Physiol. (London) 230:613–618.
DeReuck, J. and Willams, J. (1975): J. Neurol. 208:309–314.
Drachman, D.B. (1972): J. Physiol. (London) 226:619–627.
Edstrom, A. and Mattsoon,H. (1972): J. Neurochem. 19:1717–1729.
Engel, A.G., Lambert, E.H. and Santa, T. (1973): Neurology 23:1273–1281.
Evans, R.H. (1974): J. Physiol. (London) 240:517–533.
Fambrough, D.M Drachman, D.B. and Satyamurti, S. (1973): Science 182:293–295.
Feng, T.P. (1937): Clin. J. Physiol. Rep. Ser. 12:177–196.
Fenichel, G.M., Kibler, W.B., Olson, W.H. and Dettbarn, W-D. (1972): Neurology 22:1026–1033.
Fenichel, G.M., Kibler, W.B. and Dettbarn, W-D. (1974): Neurology 24:2086–1090.
Fischer, G. (1968): Histochemie 16:144–149.
Fischer, G. (1970): Experientia 26:402–403.
Fleming, W.W., McPhillips, J.J. and Westfall, D.P. (1973): Ergeb. Physiol. Biol. Chem. Exp. 68:55–119.
Groswald, D.E. and Dettbarn, W.D. (1983): Exp. Neurol. 79: 519–531.
Hall, Z. (1973): J. Neurobiol. 4:343–361.
Hobbiger, F. (1976): In Handbuch der experimentellen Pharmakologie. Erganzungswerk (ed) E. Zaimis, Springer, Berlin-Heidelberg-New York, Vol. XLII, pp. 487–582.
Jenkinson, D.H. and Nicholls, J.G. (1961): J. Physiol. (London) 159:111–127.
Karczmar, A.G. (1967): Am. Rev. Pharmacol. 2:241–276.
Kawabuchi, M., Osame, M., Igata, A. and Kanaseki, T. (1976): Experientia 32:623–625.
Laskowski, M.B., Olson, W.H. and Dettbarn, W-D. (1975): Exp. Neurol. 47:290–306.
Laskowski, M.B., Olson, W.H. and Dettbarn, W-D. (1977): Exp. Neurol. 57:13–33.
Leonard, J. and Salpeter, M.M. (1979): J. Cell Biol. 82: 811–819.
MacIntosh, F.C., Birks, R.I. and Sastry, B.P. (1956): Nature 178:1181–1183.
Miledi, R., Parker, I. and Schalow, G. (1977): J. Physiol. (London) 268:32–33P.
Otsuka, M. and Endo, M. (1960): J. Pharmacol. exp. Ther. 128:273–282.
Otsuka, M. and Nonomura, Y. (1963): J. Pharmacol. exp. Ther. 140:41–45.
O’Brien, R.A.D., Osterberg, A.J.C. and Vrbova, G. (1980): Neuroscience 5:1367–1379.
Parsons, R.L. and Nastuk, W.L. (1969): Am. J. Physiol. 217: 364–369.
Poberai, M. and Savay, G. (1976): Acta Histochem. 57:44–48.
Poberai, M., Savay, G. and Osillik, B. (1972): Neurobiology 2:1–7.
Preusser, H.J. (1967): Z. Zellforsch. Mikrosk. Anat. 80: 436–457.
Riker, W.F., Jr. and Okamoto, M. (1969): Ann. Rev. Pharmacol. 9:173–208.
Roberts, D.V. and Thesleff, S. (1969): Eur. J. Pharmacol. 6:281–285.
Salpeter, M.M., Kasprzak, H., Feng, H. and Fertuck, H. (1979): J. Neurocytol. 8:95–115.
Thesleff, S. and Quastel, D.M.J. (1965): Ann. Rev. Pharmacol. 5:263–284.
Wecker, L. and Dettbarn, W-D. (1975): Arch. Int. Pharmacodyn. Ther. 217:236–245.
Wecker, L. and Dettbarn, W-D. (1976): Exp. Neurol. 51:281–291.
Wecker, L. and Dettbarn, W-D. (1977): Exp. Neurol. 57:94–101.
Wecker, L., Kiauta, T. and Dettbarn, W-D. (1978): J. Pharmacol. Exp. Ther. 206:97–104.
Wecker, L., Mrak, R.E. and Dettbarn, W-D. (1982): J. Environ. Pathol. Toxicol. Oncol. 5:575–579.
Werner, G. and Kuperman, A.S. (1963): In Handbuch der experimentellen Pharmakologie. Erganzungswerk (ed) G.B. Koelle, Springer, Vol. XV, pp. 570–678.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Dettbarn, WD. (1986). Acetylcholinesterase and the Maintenance of Neuromuscular Structure and Function. In: Hanin, I. (eds) Dynamics of Cholinergic Function. Advances in Behavioral Biology, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5194-8_69
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5194-8_69
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5196-2
Online ISBN: 978-1-4684-5194-8
eBook Packages: Springer Book Archive